Clinical Trial Update: Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification [NA]

View source ↗

Summary

Clinical trial update examining celecoxib as primary prophylaxis to prevent combat-related heterotopic ossification.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterotopic Ossification

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Ossification, Heterotopic | NA | Status: UNKNOWN